3,419
Views
30
CrossRef citations to date
0
Altmetric
Economic Evaluations

Evaluating the performance of a predictive modeling approach to identifying members at high-risk of hospitalization

, , , , , , , , & show all
Pages 228-234 | Received 10 Jun 2019, Accepted 08 Sep 2019, Published online: 24 Sep 2019
 

Abstract

Aims: To evaluate the risk-of-hospitalization (ROH) models developed at Blue Cross Blue Shield of Louisiana (BCBSLA) and compare this approach to the DxCG risk-score algorithms utilized by many health plans.

Materials and Methods: Time zero for this study was December 31, 2016. BCBSLA members were eligible for study inclusion if they were fully insured; aged 80 years or younger; and had continuous enrollment starting on or before June 1, 2016, through time zero. Up to 2 years of historical claims data from time zero per patient was included for model development. Members were excluded if they had cancer, renal failure, or were admitted for hospice. The Blue Cross ROH models were developed using (1) regularized logistic regression and (2) random decision forests (a tree ensemble learning classification method). All models were generated using Scikit-learn: Machine Learning in Python. Prognostic capabilities of DxCG risk-score algorithms were compared to those of the Blue Cross models.

Results: When stratifying by the top 0.1% of members with the highest ROH, the Blue Cross logistic regression model had the highest area under the receiving operator characteristics curve (0.862) based on the result of 10-fold cross-validation. The Blue Cross random decision forests model had the highest positive predictive value (49.0%) and positive likelihood ratio (61.4), but sensitivity, specificity, negative predictive values, and negative likelihood ratios were similar across all four models.

Limitations: The Blue Cross ROH models were developed and evaluated using BCBSLA data, and predictive power may fluctuate if applied to other databases.

Conclusions: The predictability of the Blue Cross models show how member-specific, regional data can be used to accurately identify patients with a high ROH, which may allow healthcare workers to intervene earlier and subsequently reduce the healthcare burden for patients and providers.

JEL CLASSIFICATION CODES:

Transparency

Declaration of funding

This research was performed by Blue Cross Blue Shield of Louisiana and did not receive any specific grant from outside funding agencies in the public, commercial, or not-for-profit sectors.

Declaration of financial/other interests

This research was performed internally by Blue Cross Blue Shield of Louisiana, and authors did not have any competing financial interests or outside funding. JME peer reviewers on this manuscript have no relevant financial or other relationships to disclose.

Author contributions

JH and CN developed the model, performed the analyses, and drafted the paper; XY, YZ, and JO contributed to analysis and critical paper revisions; DC, JC, TB, VW, and SN supported data interpretation.

Acknowledgements

No assistance in the preparation of this article is to be declared.

Previous presentations

A version of this research was presented as a poster at the 2019 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) conference in New Orleans, Louisiana.